Macular degeneration risk increases with age because, like many of the body’s tissues, the tissues in our eyes break down over time. Macular degeneration has two forms: wet and dry. More than 35 ...

Researchers reviewed the original retinal scans of participants in the Age-Related Eye Diseases Studies ... atrophy progression to the fovea in age-related macular degeneration, Ophthalmology ...

The aim of this treatment was to destroy the CNV in order to preserve macular function; the success is strongly dependent on its ability to eradicate the CNV without destroying the fovea.

Photodynamic therapy with verteporfin of CNV represents an advancement in the treatment of myopic macular degeneration complicated by CNV. The aim of PDT is to treat CNV, especially located into ...